Tag: blood clots

Vitamin B12 And Folic Acid Reduce The Risk Of Blood Clots In The Brain

Claus Hancke

October 31, 2005

After Americans enriched their diet with folic acid in 1996, the frequency of blood clots in the brain was reduced by 15%. Now research shows that added supplementation of Vitamin B12 will markedly lower this risk even further.

Immediately, it sounds simple: People with high levels of the amino acid homocysteine in the blood have an increased risk of blood clots in the brain and in the heart. You also know that you can lower homocysteine with folic acid and, to a lesser extent, with B6 and B12 vitamins. When the Americans began to enrich cereal products with folic acid from 1996, both the average American’s homocysteine and the rate of blood clot in the brain decreased by about 15% in three years.

“The money fits”, and then the result is almost obvious in advance, if you want to conduct a lottery experiment, where every other participant gets folic acid, B6 and B12 vitamins. Of course, they get fewer blood clots in the brain.

But the reality is more varied. In Norway, such an experiment (NORVIT) was conducted with 3,750 patients who had just survived a blood clot in the heart. For 3.5 years, they were supplemented with either folic acid (0.8 mg), vitamin B6 (40 mg), both or blind tablets (placebo). Among those who only received folic acid, mortality decreased approx. 10%, but not statistically certain. But in the other two groups the death tolls were increased, not statistically certain either.

Perhaps it is too late to start taking supplements when you are already severely calcified. Or, as will appear, perhaps it was more decisive that the Norwegians “forgot” to give the participants vitamin B12.

An experiment has also been carried out in the USA (VISP). It was with people who had recovered from a blood clot in the brain, but had an increased risk of a new one. Admittedly, the Americans did not initially find any effect either. Supplementation of folic acid (2.5 mg), vitamin B6 (25 mg) and vitamin B12 (0.4 mg) did not reduce or improve mortality or risk of blood clots in the brain. Therefore, the experiment was simply stopped after two years. It was useless, they thought.

B12 is useful if it is absorbed
A close explanation could be the aforementioned enrichment of cereal products with folic acid. After all, the average homocysteine had already fallen by approx. 15% in the Americans. During the trial, it only dropped a further 2%.

But the Americans have since studied the numbers more closely. In doing so, they discovered one important source of error in particular: Many of the 3,680 elderly participants had reduced absorption of vitamin B12 from the gut and therefore had relatively little B12 in their blood (less than 250 pmol/l). This is often seen in the elderly, and it is now known that these elderly need supplements of at least 1,000 micrograms of vitamin B12 per day. But the participants had only received 400.

What would it look like if you now disregarded these participants and concentrated on those with normal B12 uptake? It was decided to investigate. At the same time, participants with reduced kidney function were disregarded, as they also respond sluggishly to these supplements. Finally, participants who were previously receiving medical treatment with B12 were naturally disregarded.

There remained 2,155 people who had no problems absorbing B12. In this large group, the supplements both lowered homocysteine further and reduced the overall risk of death, blood clot in the heart or blood clot in the brain – by 21%! The treatment helped anyway; even a lot when the ability to absorb B12 was intact.

As stated, it appears that the fortification of cereal products with folic acid has reduced the Americans’ risk of blood clots in the brain by approx. 15%. Now it seems that a solid supplement of vitamin B12 on top of that can reduce it significantly more – but the many elderly people, who absorb vitamin B12 poorly, presumably need larger supplements.

This is the result at the moment. It must be verified before it is approved. But the indications are there.

By: Vitality Council

References:
1. Toole JF, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004 Feb 4;291(5):565-75.
2. Bonaa KH. NORVIT: Randomized trial of homocysteine-lowering with B-vitamins for secondary prevention of cardiovascular disease after acute myocardial infarction. Program and Abstracts from the European Society of Cardiology Congress 2005; September 3-7, 2005; Stockholm, Sweden. Hot Line II. Iflg. Linda Brooks. NORVIT: The norwegian vitamin trial. Medscape sept. 2005. (Ikke publiceret i trykt medie)
3. Spence DJ et al. Vitamin intervention for stroke prevention trial. An efficacy analysis. Stroke 2005;36:2404-2409.

jama.ama-assn.org
www.medscape.com
stroke.ahajournals.org
www.iom.dk

You Must Plug The Hole Before The Boat Sinks

Claus Hancke

October 11, 2005

A Norwegian study has shown that if you have already experienced an acute myocardial infarction, the risk of another such infarction will not be reduced by taking folic acid, Vitamin B6, and Vitamin B12, even if homocysteine levels are lowered thereby.
If you get a great deal of folic acid, the blood content of the amino acid homocysteine will be relatively low. So much is certain. When the content is low, the risk of blood clots in the heart or brain hemorrrhage – other things being equal – is also low. It is also safe, but both are statistics only.

With these facts in the bag, one is tempted to think that supplementation with folic acid must be a good idea. As you know, folic acid is the B vitamin that young women should take to avoid having children with spina bifida. One can agree with the American Heart Association, which advises everyone to get 0.4 mg of folic acid a day, the same dose that women should take as a supplement.

In Tromsø in Norway, the so-called NORVIT trial (Norwegian Vitamin Trial) was the first to test whether supplements also help heart patients who have already had a blood clot in the heart. If the media is to be believed, it ended with a scare.

The results, which were presented in September at this year’s congress of the European Society of Cardiology (ESC), led directly to warnings against folic acid in the press: B vitamins could be dangerous for heart patients, it said, and our own Danish heart association was quick to announce, that folic acid is “still” not recommended for heart patients – even though the month before was said something close to the opposite.

But, as is so often the case, the reports were misleading. Strictly speaking, the Norwegian trial did not show that folic acid is dangerous. If you want to argue that it showed anything at all, it was that the risk of heart attack, stroke, or death decreased—albeit by only a few percent—in those who took 0.8 milligrams of folic acid a day for 3.5 years . However, this was not statistically certain.

The fact is that there were in fact not one, but three trials, with a total of 3,750 people, all of whom had had blood clots in the heart. One showed that a combination of folic acid, vitamin B6 and B12 led to approx. 20% more cases of blood clots in the heart than placebo (cheat pills). The second – the only one where only folic acid was used – showed no difference in reality. There was also no difference in the third trial, where the participants only received vitamin B6.

In one area, the experiments turned out to be successful: those who received folic acid achieved a drop in the blood homocysteine content of approx. 30%. Enough so that one could hope for a nice drop in the number of new blood clots. Which did not appear.

But the questions arise: Is it appropriate for heart patients to be careful about taking folic acid, vitamin B6 and vitamin B12 at the same time?
Or are we talking about completely different anatomical conditions with secondary prophylaxis than there are with primary prophylaxis? After all, you have had a blood clot.

Also at the congress, the ESC’s designated commentator, Ian Graham, doubted the result. He believed that the experiment might have been too small and too complicated to be credible.

One can go a step further and think that the result is purely due to chance. In any case, it is not supported by any theory.
It is more likely that folic acid is simply not suitable for preventing blood clots in severely arteriosclerotic patients. – In other words secondary prophylaxis.

There is a lot of evidence that folic acid – and low homocysteine – slows the development of atherosclerosis in healthy people – i.e. primary prophylaxis. But the usefulness of this function diminishes when the calcification is already very advanced. The bottom plug must be inserted before the boat is sunk.

If folic acid is to prevent blood clots, you probably have to start in good time. On the other hand, the vitamin has other benefits. Among other things. experiments convincingly indicate that it helps to keep the brain young, even in the elderly.

By: Vitality Council

Reference:
Bonaa KH. NORVIT: Randomized trial of homocysteine-lowering with B-vitamins for secondary prevention of cardiovascular disease after acute myocardial infarction. Program and Abstracts from the European Society of Cardiology Congress 2005; September 3-7, 2005; Stockholm, Sweden. Hot Line II. Iflg. Linda Brooks. NORVIT: The Norwegian vitamin trial. Medscape Sept. 2005. (Not published in a printed media).

www.medscape.com/viewprogram/4494_pnt
www.iom.dk

Vitamin E Protects Against Blood Clots And Brain Haemorrhages

Claus Hancke

August 9, 2005

Healthy women over 65 can lower their risk of serious consequences of arthrosclerosis by 25 %. This is confirmed by the world’s longest study of vitamin E, so far.

In 1997 44 % of all American cardiologists regularly used antioxidants, especially vitamin E, to prevent coronary thrombosis and strokes. The confidence in vitamin E was so strong that it surpassed the confidence in aspirin, which was only used by 42 %.

The cardiologists relied on the universal theory that arthrosclerosis arises when cholesterol is oxidized and that vitamin E, amongst other things, prevents this oxidization. Unfortunately solid evidence that vitamin E truly protects against arthrosclerosis, and thereby prevents thromboses, has been lacking. Large randomized studies have been disappointing, but also encumbered by obvious faults. Everything is shrouded in doubt. But if the doctors have stopped using vitamin E in disappointment, maybe they will begin using it again now.

The occasion is the largest and longest randomized study up until now with vitamin E. It showed that when healthy women over 65 received vitamin E as a supplement, their risk of suffering a coronary thrombosis or a stroke decreased by 26 %. And not only was the incidence lowered, the diseases also became less dangerous. The total mortality rate was approximately halved (to 51 %).

Other studies of vitamin E have been relatively short, and have had participants who suffered from serious arthrosclerosis. However this study lasted ten years, and the participants were healthy. Exactly because they did not suffer seriously from arthrosclerosis from the beginning, it was hoped that it was not too late to prevent it. A total of 20,000 women received 600 units of natural vitamin E (alpha-tokoferol) every other day for ten years. Just as many other women were given a placebo (fake pills).

The women who were over 65 benefited. However, the large majority was younger than 65. They had no obvious benefits from the treatment. 18,000 women under 65 received vitamin E. 352 of these suffered a coronary thrombosis or a stroke, some with a fatal outcome. That number was eleven higher than amongst the 18,000 who received placebos. A small and random difference. Apparently vitamin E did not benefit the younger women.

For comparison only 2 times 2000 women over 65 participated. In the group receiving vitamin E, there were 130 cases of either cardiac thrombosis or stroke. In the placebo group there were 46 cases more. This difference is relatively large, and statistically quite certain.

But why does vitamin E not benefit the younger? The obvious answer is that maybe it does, but younger women more seldom suffer cardiac thrombosis, and the potential effect is difficult to measure. In the course of the ten years the study ran, less than two percent of those under 65 suffered a cardiac thrombosis or a stroke. Those older, of course had a bigger risk (about eight percent). One can speculate that despite the neutral numbers, the younger group did in fact become less atherosclerotic because of the vitamin E supplement. No one knows, since a direct measurement of the blood vessels was not conducted. The only measurement for the degree of arthrosclerosis was the rough numbers for cardiac thrombosis and stroke.

If seen under the same light, statistically there was only tendency towards benefit from vitamin E. It is a natural consequence of the fact that there were nine times as many young participants, as there were older. The researchers did however choose to conclude on the basis of this result. They believe that the study does not warrant a general recommendation of vitamin E for the prevention of cardio-vascular disease. With regards to those over 65, it is being said that the result deviates from “the total knowledge” and should be investigated further.

This is a somewhat weak comment. A more direct comment came from Maret Taber who is professor at the Linus Pauling Institute in California and one of the World’s leading vitamin E experts:

“Vitamin E has its clear value in the fight against cardiac disease and other degenerative sufferings. It is most important for smokers, persons suffering from hypertension and those who eat an unhealthy diet.”

By: Vitality Council

Reference:
Lee, I-Min. Vitamin E in the primary prevention of cardiovascular disease
and cancer. The Womens Health Study: A randomized controlled trial. JAMA
2005;294:56-65.

jama.ama-assn.org
www.iom.dk

Folic Acid Lowers Blood Pressure and Prevents Blood Clots

Claus Hancke

April 19, 2005

While folic acid lowers blood pressure, the dose must be large enough to have this effect. Diet alone will not provide a significantly large enough dose, so it is essential to take folic acid as a supplement. The vitamin also simultaneously protects the heart and brain against blood clots.

It has long been documented that the B vitamin, folic acid, prevents the birth defect Spina bifida. For eight years, Canada has fortified all flour with folic acid and has thus prevented 80% of these sad cases. Enrichment is also required in the United States, but in Denmark, expectant mothers must manage on their own. It’s their own problem to find out to take a supplement – before they get pregnant!

The main source of folic acid is green vegetables (“folium” means “leaf”). Many people do not like them, and a lack of folic acid is therefore the most common vitamin deficiency. Unfortunately, this not only harms the unborn, but also adults, where it increases mortality from both blood clots in the heart and from apoplexy (blood clot in the brain). Not only that: the deficiency probably also increases the tendency to high blood pressure.

The previously unknown connection with blood pressure was discovered when 156,000 American nurses were observed for eight years. 1) Their risk of developing high blood pressure as a young adult (27-44 years old) was only half as high when they received one mg of folic acid per day as when they received only 0.2 mg. The latter amount is a very common dietary intake in both the United States and Denmark (average 0.25 mg per day). On the other hand, it is almost impossible to get 1 mg, five times as much, without supplementation.

With regard to stroke and blood clots in the heart, very interesting knowledge has emerged in recent years:

In the USA, where flour fortification was introduced in 1996, mortality from stroke has since fallen very dramatically, in all population groups and for both men and women, i.e. quite independently of lifestyle.

Before 1996, the annual decline in mortality from stroke was just over one percent and could be attributed to better treatment and prevention. But in the following three years, mortality fell 3-4 times as much, a total of 10-15%! This has only been statistically explained by the fact that the typical American now has twice as much folic acid in their blood as before. 2)

Stroke is also particularly harmful if you lack folic acid. This was recently demonstrated in mice. They were artificially induced to have a stroke by simply clamping an artery to the brain. It turned out that the brain damage was only half as extensive when the mice had received enough folic acid as when they suffered from a deficiency. 3)

But apparently folic acid also protects the heart. This was most recently revealed when Italian doctors examined approximately 900 patients who were hospitalized with and without a blood clot in the heart.

They divided all the hospitalized patients according to how much folic acid they received daily, and of the third who received the least folic acid, the researchers found that most were admitted to the cardiac ward. This third had a risk that was twice as high as those who received the most folic acid. When taking into account the intake of vitamin B6 – B6 works together with folic acid – those who received the most had a relative risk of only 29%. 4)

It is not folic acid itself that protects the heart and brain. However, folic acid lowers the blood’s level of the harmful amino acid homocysteine, which attacks blood vessels.

Approximately 10% of the population has, without knowing it, a hereditary increase in homocysteine (and therefore needs more folic acid). Recently, it has been shown that these 10% suffer from stroke significantly more often than others. 5, 6). It was already known that exactly the same is true for blood clots in the heart. 7)

No one has yet conducted blinded trials where supplementation has effectively lowered blood levels of homocysteine. This is now encouraged. 8) However, with the existing knowledge, it seems wise to take a supplement.
The ideal is perhaps 0.8 mg (800 micrograms) per day.

By: Vitality Council

References:
1. Forman JP, Rimm EB, Stampfer MJ, Curhan GC. Folate intake and the risk of incident hypertension among US women. JAMA. 2005 Jan 19;293(3):320-9.
2. American Heart Association’s 44th annual Conference on Cardiovascular Disease Epidemiology and Prevention. carole.bullock@heart.org
3. Endres M, Ahmadi M, Kruman I, Biniszkiewicz D, Meisel A, Gertz K. Folate deficiency increases postischemic brain injury. Stroke. 2005 Feb;36(2):321-5. Epub 2004 Dec 29.
4. Taivani A et al. Folate and vitamin B6 intake and risk of acute myocardial infarct in Italy. Eur J Clin Nutr 2004;58:1266-72.
5. Al-Delaimy WK, Rexrode KM, Hu FB, Albert CM, Stampfer MJ, Willett WC, Manson JE. Folate intake and risk of stroke among women. Stroke. 2004 Jun;35(6):1259-63.
6. Casas JP et al. Homocysteine and stroke: Evidence on a causal link from mendelian randomisation. The Lancet 2005;365: 224-32.
7. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group. MTHFR 677C– T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 2002 Oct 23-30;288(16):2023-31.
8. S Schwammenthal et al. Homocysteine, B-vitamin supplementation, and stroke prevention. From observational to interventional trials. Lancet Neurol. 2004;3(8):493.

jama.ama-assn.org
www.nature.com
www.stroke.org
www.thelancet.com
www.iom.dk

Folic Acid: It Seems Wise to Take a Supplement

Claus Hancke

February 7, 2005

Folic acid reduces the blood pressure, but only if you take a folic acid supplement, as you will not get enough simply through your diet. At the same time, folic acid protects your heart and brain from blood clots.

Since long, it has been documented that the B-vitamin folic acid (B9) prevents congenital neural tube defects. In Canada, all kinds of flour have been enriched with folic acid during the past 8 years, and 80% of the congenital neural tube defects have thus been prevented. In the USA, enrichment is also obligatory, but in Britain, expectant mothers are left to themselves. They have to figure out for themselves to take a supplement – before they become pregnant!

The main source of folic acid is leafy green vegetables (the latin “folium” means “leaf”). Many people do not like these leafy greens and folic acid deficiency is therefore more common than any other vitamin deficiency. Unfortunately, the deficiency probably does not only harm the unborn baby but does also increase the mortality of coronary thrombosis and cerebral apoplexy in adults. But this is not all: Folic acid deficiency probably also increases the risk of hypertension.

The connection between folic acid deficiency and hypertension that has been unknown till now was discovered when an eight-year study was concluded involving 156,000 American nurses *1). The risk of the nurses having hypertension while being 27 – 44 years of age was only half as great when they took 1 mg (1000 mcg.) of folic acid a day compared to when they took 0.2 mg. In both the US and Britain, 0.2 mg. is just below the average daily folic acid intake which is 0.25 mg. It is almost impossible to get 1 mg. of folic acid a day – which is four times as much – without taking a supplement.

With regard to apoplexy and coronary thrombosis, much interesting knowledge has been produced during recent years:
In the US, where enrichment of flour with folic acid began in 1996, the mortality rate following apoplexy has droppped dramatically – in all groups of society, that is, and for both men and women – so the results are rather regardless of lifestyle, etc.

Before 1996, the annual drop in mortality as a result of apoplexy was about 1%. This drop was the result of improved treatment and prophylaxis. However, in the succeeding three years, mortality rates dropped three times as fast, i.e. with a total of 10 – 15%! Statistically, this has been explained by the fact that the average American now has twice as much folic acid in his/her blood as before *2).

Moreover, apoplexy is far more dangerous if you are deficient in folic acid. This was recently demonstrated on mice. They were given an artificial apoplexy in that their cerebral artery was simply clamped. It turned out that the cerebral damage was only half as great in the mice that had been given enough folic acid *3).

Folic acid seems to be able to protect the heart as well. This appeared most recently when Italian doctors studied 900 patients hospitalized with or without coronary thrombosis. The patients were divided into three groups according to their estimated daily intake of folic acid. Among the patients admitted to the cardiology department, most of them belonged to the group that got the least folic acid!

The third of the patients that got the least folic acid had twice as great a risk compared to the third of the patients that got the most folic acid. When vitamin B6 intake was also taken into account (vitamin B6 collaborates with folic acid), the ones who got the most folic acid only had a relative risk of 29% *4).

It is not the folic acid itself that protects the heart and the brain. However, folic acid reduces the blood content of the harmful amino acid homocysteine which attacks the blood vessels.

About 10% of the population are unaware that they have a hereditarily increased homocysteine level in their blood (and therefore need more folic acid). Recently, it was discovered that these 10% suffer apoplexy significantly more often than others *5, 6). It was already known that these people already have an increased risk of suffering coronary thrombosis *7).

Nobody has yet performed a blinded study in which supplements have been used to efficiently lower the blood contents of homocysteine. However, this kind of research is now being encouraged *8). Yet, with our existing knowledge, it seems wise to take a folic acid supplement. The ideal dosage may be around 0.8 mg. (800 mcg.) a day.

By: Vitality Council

References:
1. Forman JP, Rimm EB, Stampfer MJ, Curhan GC. Folate intake and the risk of incident hypertension among US women. JAMA. 2005 Jan 19;293(3):320-9.
2. American Heart Association’s 44th annual Conference on Cardiovascular Disease Epidemiology and Prevention.carole.bullock@heart.org
3. Endres M, Ahmadi M, Kruman I, Biniszkiewicz D, Meisel A, Gertz K. Folate deficiency increases postischemic brain injury. Stroke. 2005 Feb;36(2):321-5.
4. Taivani A et al. Folate and vitamin B6 intake and risk of acute myocardial infarct in Italy. Eur J Clin Nutr 2004;58:1266-72
5. Al-Delaimy WK, Rexrode KM, Hu FB, Albert CM, Stampfer MJ, Willett WC, Manson JE. Folate intake and risk of stroke among women. Stroke. 2004 Jun;35(6):1259-63.
6. Casas JP et al. Homocysteine and stroke: Evidence on a causal link from mendelian randomisation. The Lancet 2005;365: 224-32
7. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group. MTHFR 677C–>T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 2002 Oct 23-30; 288(16):2023-31.
8. S Schwammenthal et al. Homocysteine, B-vitamin supplementation, and stroke prevention. From observational to interventional trials. Lancet Neurol. 2004;3(8):493-5.

jama.ama-assn.org
www.lancet.com
stroke.ahajournals.org
www.iom.dk

Vitamin C Can Protect the Heart

Claus Hancke

December 20, 2004

A new meta-analysis was published some weeks ago with the positive conclusion that high doses of Vitamin C can reduce the risk of coronary thrombosis (blood clots) in the heart by 25%.

Nine scientific studies with a total of 290,000 people who did not suffer from cardiac disease were thoroughly analysed by a group of researchers from several large centres in Denmark, Sweden, Finland, Israel, and the USA.

In this group, during the course of ten years, approx. 4600 large coronary thromboses were discovered. Then, various factors that could influence this result were analysed.

Documentation that large amounts of fruit and vegetables reduce this cardiovascular risk is vast, and therefore, it was important to the researchers to distinguish between the ones who had only received their vitamins through their diet and the ones who had supplemented their diet with dietary supplements.

The research group found out that a daily dietary supplement with a high dose of Vitamin C with large statistic certainty (p<0.001) could reduce the risk of coronary thrombosis with 25% compared to the ones who did not take any supplements.

The dose of vitamin C to take for this reduced risk to set in was more than 700 mg. a day. This more or less equals the amount of Vitamin C that can be found in: 15 fresh oranges, 35 fresh apples, 75 fresh bananas, or ½ kg. of fresh blackcurrant. These amounts of fruit should be eaten every day – so there must be an easier way!

Moreover, the analysis confirms the results of a study that was made earlier this year that showed that Vitamin C reduces hs-CRP (high-sensitive C-reactive protein), which is a blood test that can predict the cardiac risk in a much more secure way than any cholesterol values in the world.

The analysis could only give weak support to the hypothesis that Vitamin E reduces the risk of coronary thrombosis. This result was not statistically certain.

By: Vitality Council

Reference:
Knekt P, Heitmann Berit L, Augustsson Katarina et al: Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts.American Journal of Clinical Nutrition (vol. 80, issue 6, pp1508-1520, 2004).

www.ajcn.com
www.iom.dk

Broccoli and Spinach are Not Likely to Affect INR Blood Test

Claus Hancke

December 10, 2004

Promising Dutch study of Vitamin K. The somewhat cryptic headline is probably nonsense to most people, but nevertheless has great importance to all those taking blood-thinning (anticoagulating) medicines such as Marevan (Warfarin) and who are doing the regular blood test control, called INR.

If you are undergoing treatment with anticoagulant drugs such as Marevan, you should regularly be tested with a blood test called INR.

This blood test is designed to estimate if the dose you receive is correct, but it should also prevent overdosing in which the blood would get “too thin”. This condition is dangerous and can result in internal bleeding.

12 healthy volunteers were included in a study in which they were given a correct dosage of anticoagulants for 13 weeks and adjusted to a maintenance dose with a constant and stable INR value that would prevent them from forming blood clots.

Then, they were given increasingly large daily doses of vitamin K from 50 mcg. to 500 mcg. during the course of one week. Not until the dose reached 150 mcg. of vitamin K a day taken as a dietary supplement, was any effect on INR observed. Even at this dose, INR was only affected in 3 out of the 12 trial subjects.

When the trial subjects were given food that is particularly rich in vitamin K, i.e. broccoli and spinach, there was no clinically relevant effect on INR because the effect was so transient, and the authors suggest that the reason might be a poor bioavailability of the vegetables. This may be surprising, as kale, spinach, and broccoli can contain up to 400 mcg. of vitamin K per 100 g.

Doses of 100 mcg. vitamin K as an easily absorbable dietary supplement had no effect on INR.

If this study on healthy, young trial subjects can be repeated with the same result on patients with a predisposition to forming blood clots, it would make life significantly easier on a great number of people who every day stare in despair at the long list of foods containing vitamin K that they are not allowed to eat while taking Marevan.

By: Vitality Council

Reference:
Schurgers LJ, Shearer MJ, et al: Effect of Vitamin K Intake on the Stability of Oral Anticoagulant Treatment. Dose-Response Relationships in Healthy Subjects. Blood 2004;104(9):2682-2689.

www.bloodjournal.org
www.iom.dk

Fish Oil for the Heart

Claus Hancke

March 7, 2003

Essential oils in fish oil can prevent heart disease in elderly people. Quite many consumers and doctors have good experiences with this, but now it has also been confirmed by a study, recently published in the American Journal of Clinical Nutrition.

The trial included 360 persons at the age of 65, and the researchers found that a high concentration of the fatty acids DHA and EPA is associated with a lower risk of dying of blood clots in the heart.

– “Again, this is a good example of a preventive measure with natural substances such as fish oil, pays off” says Claus Hancke, chairman of the Vitality Council.

–  Fish oil reduces the risk of both blood clots and atherosclerosis, so there is common sense in taking fish oil, especially if you do not eat as much fish.

– Research results of this type unfortunately receive far too little attention in Denmark, on the contrary, we have often been told that dietary supplements are not useful at all. As a consumer, therefore, it can be difficult to know what to believe.

– Therefore, I believe that a sober-minded information about dietary supplements such as fish oil should be one of the obvious tasks for a future Council for Exercise and Nutrition, says Hancke, who is a specialist in general medicine and General Manager of the Department of Orthomolecular Medicine in Lyngby.

Science today knows very little about the link between heart disease in the elderly and the body’s content of these fatty acids, and therefore studies like this are welcomed by the doctors who work with orthomolecular medicine on a daily basis, popularly speaking: Biological medicine.

By Vitality Council

Reference:
American Journal of Clinical Nutrition, Vol. 77, No. 2, 319-325, February 2003.

www.ajcn.org
www.iom.dk